MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells ; volume:14 ; number:1 ; day:17 ; month:1 ; year:2012 ; pages:1-13 ; date:2.2012
Breast cancer research ; 14, Heft 1 (17.1.2012), 1-13, 2.2012
- Urheber
-
Lappano, Rosamaria
- Beteiligte Personen und Organisationen
-
Santolla, Maria Francesca
Pupo, Marco
Sinicropi, Maria Stefania
Caruso, Anna
Rosano, Camillo
Maggiolini, Marcello
SpringerLink (Online service)
- DOI
-
10.1186/bcr3096
- URN
-
urn:nbn:de:1111-2016032414331
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lappano, Rosamaria
- Santolla, Maria Francesca
- Pupo, Marco
- Sinicropi, Maria Stefania
- Caruso, Anna
- Rosano, Camillo
- Maggiolini, Marcello
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mechanism of antagonist ligand binding to REV-ERBα
Predictive features of ligand‐specific signaling through the estrogen receptor
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Antagonist
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
Katacine is a new ligand of CLEC-2 that acts as a platelet agonist
Estrogen‐Induced LncRNA, LINC02568, Promotes Estrogen Receptor‐Positive Breast Cancer Development and Drug Resistance Through Both In Trans and In Cis Mechanisms
Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site
Tweet acts and quote-tweetable acts
An actinobacteria lytic polysaccharide monooxygenase acts on both cellulose and xylan to boost biomass saccharification
Mechanism of antagonist ligand binding to REV-ERBα
Predictive features of ligand‐specific signaling through the estrogen receptor
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Antagonist
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
Katacine is a new ligand of CLEC-2 that acts as a platelet agonist
Estrogen‐Induced LncRNA, LINC02568, Promotes Estrogen Receptor‐Positive Breast Cancer Development and Drug Resistance Through Both In Trans and In Cis Mechanisms
Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site
Tweet acts and quote-tweetable acts
An actinobacteria lytic polysaccharide monooxygenase acts on both cellulose and xylan to boost biomass saccharification
Mechanism of antagonist ligand binding to REV-ERBα
Predictive features of ligand‐specific signaling through the estrogen receptor
Development of an orthogonal ligand-receptor pair based on synthetic estrogen analogs and engineered estrogen receptor for transcriptional regulation
Antagonist
Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity
Katacine is a new ligand of CLEC-2 that acts as a platelet agonist
Estrogen‐Induced LncRNA, LINC02568, Promotes Estrogen Receptor‐Positive Breast Cancer Development and Drug Resistance Through Both In Trans and In Cis Mechanisms
Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers
Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site
Tweet acts and quote-tweetable acts